AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $186.11, giving the company a market capitalization of 290.05B. It carries a P/E multiple of 26.24 and pays a dividend yield of 1.71%.
On 2026-11-03, AstraZeneca(AZN) stock traded between a low of $183.75 and a high of $187.94. Shares are currently priced at $186.11, which is +1.3% above the low and -1.0% below the high.
AstraZeneca(AZN) shares are trading with a volume of 2.7M, against a daily average of 3.27M.
During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $153.41 at its lowest and $212.71 at its peak.
AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s NCT07370194 study, officially titled “Investigating...
AstraZeneca PLC‘s (NYSE:AZN) solid third-quarter results, along with a shift in the clinical trial results for a lung cancer drug candidate, "remove overhangs,"...
As of Nov. 2, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading d...
Analyst ratings
91%
of 11 ratingsMore AZN News
On its third-quarter 2026 earnings call, held on Oct. 30, 2026, AstraZeneca (AZN +7.02%) reported total revenue grew 7% and core earnings per share increased 14...
AstraZeneca plc ((GB:AZN)) has held its Q3 earnings call. Read on for the main highlights of the call. AstraZeneca’s latest earnings call struck a firmly upbea...
Technology AstraZeneca Gaps Up To Three-Month High As CEO Calls Out $20 Billion Potential Licensing AstraZeneca (AZN) stock gapped higher Friday as cancer drugs...
AstraZeneca Plc (NYSE:AZN) on Friday posted better-than-expected third-quarter 2026 results. The European drug giant reported core earnings of $2.79 per share,...
AstraZeneca (AZN Quick QuoteAZN - Free Report) reported third-quarter 2026 core earnings of $2.79 per share, which beat the Zacks Consensus Estimate of $2...
AstraZeneca reiterated its 2026 guidance. Dado Ruvic / Reuters AstraZeneca AZN 2.26 %increase; up pointing triangle reported increases in revenue and profit fo...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new SELENE 2 trial targets a fast‑growing market where diabetes and...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.